Clinical data also show that systemic levels of pro-inflammatory cytokines, including tumor necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6, and CRP are elevated in patients with both type 1 and type 2 diabetes [21,22,23]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.